OTC16-11-10p1FIN.qxd 15/11/10 07:02 Page 1 16 November 2010 COMPANY NEWS 3 Sanofi expands in China Alliance Boots eyes 3 Chinese expansion Regulatory problems hit 4 Mucinex launch with BMP Sunstone deal Reckitt plans future 5 of Durex and Scholl Merck overcomes 6 anofi-Aventis is set to strengthen its pres- der exclusive multi-year licenses and provides Latin American drop Sence in the Chinese OTC market by ac- pharmaceutical distribution services through Sanofi-Aventis works on 7 quiring BMP Sunstone and its portfolio of subsidiaries in Beijing and Shanghai. consumer acquisitions OTC cough/cold and women’s health brands Sanofi-Aventis said the US$10.00 per share Energy drinks boost 8 for around US$520 million (C375 million). deal had been unanimously approved by BMP OTC sales at Taisho The price tag represents around 3.5-times Sunstone’s board of directors and had received Prilosec OTC holds back 9 BMP Sunstone’s 2009 sales of US$147 million the backing of shareholders representing 23% growth at P&G and 62-times its operating profit of US$8.4 mil- of the company’s stock. Perrigo sees longevity 10 lion. The company is based in the US and oper- Combining BMP Sunstone with its exist- in store-brands ates through subsidiaries in China. ing Chinese joint venture business, Hangzhou Pfizer benefits from 12 Almost 60% of BMP Sunstone’s sales were Sanofi Minsheng Consumer Healthcare, would Wyeth’s OTC brands generated by its OTC brands, Sanofi-Aventis turn Sanofi-Aventis into a “leading consumer Key brands boost 13 said, which included China’s leading paediatric healthcare company in China”, the French firm Bayer Consumer Care cough and cold product Hao Wa Wa (Good- said, with a strong position in China’s two largest Merck eyes global future 15 Baby) and the women’s hygiene brand Kang OTC categories of cough and cold and vitamin for Consumer Care division Fu Te (Confort). and mineral supplements, each of which is worth The company also markets a portfolio of around US$2.5 billion annually. GENERAL NEWS 16 third-party products – primarily focused on Sanofi-Aventis entered the Chinese OTC Benefits of self-care will 16 paediatrics and women’s health – in China un- ■ Continued on page 15 be highlighted in the UK MARKETING NEWS 17 Beiersdorf takes Nivea 17 Meda acquires three OTC brands to travellers worldwide eda has grown its OTC business for the pany announced it would be entering the US Award rewards non-pharmacy 19 Mthird time in just over two months by ac- OTC market after acquiring the speciality phar- performance quiring three OTC brands from Dutch firm Nor- maceutical company Alaven for US$350 mil- McNeil refreshes Sudafed 20 gine for SEK540 million (C57.6 million). lion (C257 million) (OTC bulletin,10 Septem- with new names in the UK Through the acquisition, the Swedish com- ber 2010, page 1). Prilosec OTC teams up 21 pany has gained Norgine’s Pyralvex for reliev- Acquiring Alaven provided Meda with a with NFL players in US ing the pain caused by mouth ulcers, Spasmon- “strategic OTC platform in the US”, the com- Actavis offers pharmacists 22 al for treating irritable bowel syndrome and pany said, through which it could commercial- “potent” First Resort in UK Waxsol ear drops. ise “strategic pipeline opportunities”. FEATURES 24 Meda is paying almost three times the com- Meda followed the Alaven deal by acquiring bined annual sales of the brands, which are ap- BioPhausia’s portfolio of Nordic OTC brands Regulators grapple with 24 proximately SEK190 million. The majority of for SEK190 million at the end of September non-prescription supply the brands’ sales are generated in Europe, the (OTC bulletin,29 September 2010, page 1). A look at Europe’s regulatory issues company said, adding that Pyralvex was the Meda’s OTC offering has grown steadily PepTcell pursues 26 biggest-selling of the three, with annual turn- over the past few years, and now accounts for OTC partners over of around SEK90 million. more than SEK2.0 billion of Meda’s total sales, REGULARS Commenting on the deal, Anders Lönner, which the company expects to reach SEK11.4 Meda’s chief executive officer,said the acqui- billion in 2010. Events – Our regular listing 23 sition further strengthened the firm’s presence The majority of the company’s OTC sales People – Reckitt tasks Sydow 27 in the growing OTC segment. are generated by its Betadine antiseptic brand, with growing Durex and Scholl The acquisition is Meda’s third in the OTC which had sales of SEK614 million in the open- arena in recent months. In September,the com- ing nine months of 2010. OTC Ad 2010:OTC Ad 1_07 5/1/10 14:16 Page 1 Published20timesayear, OTC bulletin is suppliedinaprintedformatdesignedtoprovide you with aregular briefing on the business of consumer healthcare. Yo ur annualsubscriptionalsooffersthe addedvalue of news@OTCbulletin –afreeweekly*electronicnewsflash whichkeeps you fully updatedwith thebiggest storiesbreakinginthe consumer healthcaresector. *Published around 45 times ayear SUBSCRIPTION FORM PLEASETICK APPROPRIATE BOXES DELIVERY ADDRESS Iwould like ___________ annual subscription/s to OTC bulletin at the rate of ❏ Name____________________________________________Position________________________ £595 (£625 outsideEurope) for single copies and £345 (£375 outside Europe) for additional copies to the same address Company ________________________________________________________________________ PAYMENT OPTIONS Address__________________________________________________________________________ Ienclose acheque for £______, or the equivalent in Euros ______, drawn on aUKbank ❏ __________________________________________________________________________________ Cheques should be made payable to OTC Publications Ltd ❏ Please send me an invoice __________________________________________________________________________________ Please debit my credit card for £______ ❏ Tel___________________________________Fax ________________________________________ ❏ VISA ❏ MASTERCARD ❏ AMERICAN EXPRESS E-mail address for news@OTCbulletin ____________________________________________ Card No: Please returnformto: Three/four-digit security code: OTC bulletin,BulletinPublishing Group, OTCPublications Ltd, 54 Creynolds Lane, Solihull B90 4ER, UK. Or Faxto: +44 (0)1564 777524 Cardholder signature ______________________________________________________________ Telephone enquiries:+44 (0)1564 777550 E-mail: [email protected] Expirydate: ____________________________Date _____________________________________ Registered Office: As above.Registered in England No 2765878. VATNoGB608 0432 69 For more information visit our website at www.OTC-bulletin.com OTC16-11-10p2-3FIN.qxd 15/11/10 07:05 Page 3 COMPANY NEWS OTC Business Strategy/Trading Update Alliance Boots eyes Chinese expansion lliance Boots says it intends to become a ister David Cameron and a group of UK busi- supermarket chain Waitrose had been extended Aleading player in the Chinese market and ness leaders on a trade mission to China. during the period. A total of 12 Boots stores now has identified ways to increase its presence. Currently,Alliance Boots’ only presence in sell a combined Boots and Waitrose lunchtime A spokesperson for Alliance Boots told OTC China is the 50:50 wholesaling joint venture food offering, and a further seven incorporate bulletin that the pan-European wholesaler and with the Guangzhou Pharmaceutical Company, a larger range of lunchtime and convenience retailer was looking at “several opportunities” which was formed in January 2008 (OTC bul- foods. In addition, Waitrose is selling Boots and one might be “seized in the near future”. letin,15 February 2008, page 2). health and beauty products in 12 of its shops. No “significant” deals would be signed dur- Meanwhile, Alliance Boots reported total Sales by Alliance Boots’ international retail ing executive chairman Stefano Pessina’s two- sales by its wholesaling, retailing and contract operation increased by 8.2% – 6.7% at constant day trip to China, said the spokesperson, but manufacturing businesses up by 6.0% to £8.95 exchange rates – compared to the same period Alliance Boots planned to develop its presence billion (C10.4 billion) in the six months ended a year earlier,Alliance Boots noted, but the in China and become a leading player in the 30 September 2010 (see Figure 1). fragile state of the economy in Ireland and civil fast-growing market. unrest in Thailand had hampered trading. Pessina recently joined British Prime Min- Sales 2% ahead at Health & Beauty Turnover at the Pharmaceutical Wholesale The company’s Health & Beauty retail divi- division had grown by 7.7% to £5.91 billion sion posted turnover up by 2.0% – 1.8% on a over the period, Alliance Boots said, or 8.7% OTC bulletin constant currency basis – to £3.64 billion. Like- on a constant currency basis. for-like sales edged up by 0.3%. The company has recently expanded its 16 November 2010 Number 352 Health & Beauty’s Boots UK retail opera- wholesaling business by becoming the major- tion reported sales up by 1.8% on a like-for- ity shareholder in Turkish wholesaler Hedef Editor & Publisher: Deborah Wilkes like basis. The business had continued to grow Alliance Holding (OTC bulletin,13 August Associate Editors: Aidan Fry market share in its core health and beauty prod- 2010, page 3), and by snapping up a further Mike Rice uct categories, Alliance Boots said, thanks to 51.65% stake in Germany’s Andreae-Noris Business Editor: Matt Stewart its “strong product offering combined with ex- Zahn (Anzag) from German wholesalers Cele-